ClinicalTrials.gg
CompletedNCT02195713Updated Feb 22, 2016Results posted

Evaluation of a Novel Electronic Urine Output Monitor (eUOM)

An observational study in Oliguria and Polyuria, sponsored by Potrero Medical. Completed at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-02-22.

Sponsored by Potrero Medical · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years and older
Sex
All
01

Study summary

Urine output and urine drain line pressure were monitored while urine was drained into either:

  1. Accuryn Urine Output Monitor (Potrero Medical) OR
  2. Criticore Monitor (Bard Medical)
Read the detailed description

The purpose of this study is to determine the characteristics of urine output and drain line pressure as measured with the Accuryn urinary output monitoring system and urine output as recorded by a commercially available system (Criticore, Bard Medical) when used with a standard Foley catheter and standard urinary drainage tube.

02

Conditions studied

  • Oliguria
  • Polyuria

Browse trials for

03

In context

Polyuria

14 studies on the registry are indexed under Polyuria; 2 are open to participants now.

Browse Polyuria studies →

Lead sponsor

Potrero Medical is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

ICU patient that needs a Foley catheter

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient must ≥ 18 years of age
  • Patient has a Foley catheter and urine collection system is in place per standard clinical decision
  • Estimated length of placement of the Foley is 48 hours minimum
  • Burn injury ≥ 20% and ≤ 80% total body surface area (TBSA)
  • Subject or subject's legally authorized representative is able to give before entering the study

Exclusion criteria

Exclusion Criteria:

  • Currently pregnant or breastfeeding
  • Clinical signs or symptoms of a urinary tract infection (UTI)
  • Clinical signs or symptoms of a vaginal infection
  • Currently has bladder or urethral trauma
  • Use of drug/device therapy within the past 4 weeks
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Groups and cohorts

  • Test- Accuryn Urine Output Monitor

    Accuryn Anti-airlock Drainage System was attached to the Foley catheter and urine output / drainage line pressure was monitored.

    Device: Accuryn

  • Control- Critcore Urine Output Monitor

    A commercially available urine output monitor (Criticore, Bard Medical) was attached to the Foley catheter and urine output / drainage line pressure was monitored.

Interventions

  • DeviceAccuryn

    Accuryn is a novel electronic urine output monitor

06

What researchers measure

Primary outcomes

  1. Urine Output of SOC Device Versus Accuryn

    Urine output as recorded by the SOC when connected to a standard Foley catheter and standard urinary drainage tube will be compared to urine output recorded by Accuryn and the SOC when connected to a standard Foley catheter and the Accuryn Drainage Tube.

    Time frame: 2 - 5 days

07

Results

Posted Sep 1, 2015

Participant flow

Participant flow — Overall Study
MilestoneTest- Accuryn Urine Output MonitorControl- Critcore Urine Output Monitor
Started1010
Completed1010
Not completed00

Outcome measures

PrimaryUrine Output of SOC Device Versus Accuryn

Urine output as recorded by the SOC when connected to a standard Foley catheter and standard urinary drainage tube will be compared to urine output recorded by Accuryn and the SOC when connected to a standard Foley catheter and the Accuryn Drainage Tube.

Time frame:
2 - 5 days
Reported as:
Number · Patients with airlocks
Urine Output of SOC Device Versus Accuryn
Patients with airlocksTest- Accuryn Urine Output MonitorControl- Critcore Urine Output Monitor
Urine Output of SOC Device Versus Accuryn0 (0 to 0)5 (5 to 5)

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Test- Accuryn Urine Output Monitor———
Control- Critcore Urine Output Monitor———

Baseline characteristics

Age, Continuous
Age, Continuous(years)Test- Accuryn Urine Output MonitorControl- Critcore Urine Output MonitorTotal
Mean44 ± 2252 ± 17.949 ± 20.2
Sex: Female, Male
Sex: Female, Male(Participants)Test- Accuryn Urine Output MonitorControl- Critcore Urine Output MonitorTotal
Female213
Male7815
Region of Enrollment
Region of Enrollment(participants)Test- Accuryn Urine Output MonitorControl- Critcore Urine Output MonitorTotal
United States9918
08

Study locations

2 sites
  • Joseph M. Still Burn Center at Doctors Hospital
    Augusta, Georgia 30909, United States
  • The University of Texas Medical Branch (UTMBP)
    Galveston, Texas 77555, United States
09

References and documents

Related links

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2014, a primary completion of Feb 2015 and a completion of Feb 2015. It does not say whether these dates are actual or estimated.

Results were first posted in Sep 2015, 7 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 15, 2014
First posted
Jul 21, 2014
Start
Jul 2014
Primary completionActual
Feb 2015
CompletionActual
Feb 2015
Results first posted
Sep 1, 2015
Last update
Feb 22, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 22, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02195713
Lead sponsor
Potrero Medical
Responsible party
Sponsor
First posted
Jul 21, 2014
Start date
Jul 2014
Primary completion
Feb 2015
Completion
Feb 2015
Results posted
Sep 1, 2015
Last update
Feb 22, 2016

Study contacts

George Kramer
principal investigator · UTMB
Bruce Friedman
principal investigator · Joseph M. Stills Burn Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion